Folate levels in patients with ulcerative colitis receiving sulphasalazine

dc.contributor.author	Schoeman, M.	en_ZA
dc.contributor.author	Bezuidenhout, D. J. J.	en_ZA
dc.date.accessioned	2011-03-18T14:57:40Z
dc.date.available	2011-03-18T14:57:40Z
dc.date.issued	1984
dc.description	CITATION: Schoeman, M. & Bezuidenhout, D. J. J. 1984. Folate levels in patients with ulcerative colitis receiving sulphasalazine. South African Medical Journal, 66:415.
dc.description	The original publication is available at http://www.samj.org.za
dc.description.abstract	The question of folate deficiency in patients receiving sulphasalazine is still controversial. A random sample of patients with ulcerative colitis receiving sulphasalazine were studied to determine the clinical significance of the inhibition of folic acid absorption by the drug. No significant lowering of folate levels could be determined.
dc.description.version	Publisher’s version
dc.identifier.issn	2078-5135 (online)
dc.identifier.issn	0256-9574 (print)
dc.identifier.uri	http://hdl.handle.net/10019.1/7568
dc.language.iso	en
dc.publisher	Health & Medical Publishing Group
dc.rights.holder	South African Medical Journal
dc.subject	Folic acid	en_ZA
dc.title	Folate levels in patients with ulcerative colitis receiving sulphasalazine	en_ZA
dc.type	Article

Now showing 1 - 1 of 1